Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regina Ortmann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Business Economics|September 25, 2023
Distortional effects of separate accounting and formula apportionment on factor allocationRegina Ortmann, Erich Pummerer
Finance Research Letters|August 25, 2020
COVID-19 and investor behaviorRegina Ortmann, Matthias Pelster, Sascha Tobias Wengerek
Angewandte Chemie (International Ed. in English)|November 13, 2003
New antimalarial drugsJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
Archiv Der Pharmazie|November 13, 2007
Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activityJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
International Journal of Medical Microbiology : IJMM|August 18, 2012
The antimalarial pipeline--an updateFlorian C Schrader, Marlene Barho, Iljana Steiner, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katja Kettler, Jacek Sakowski, et al.
Archiv Der Pharmazie|September 7, 2007
Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residuesRegina Ortmann, Jochen Wiesner, Katrin Silber, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katharina Fucik, Katja Kettler, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activityRegina Ortmann, Jochen Wiesner, Armin Reichenberg, et al.
Archiv Der Pharmazie|July 5, 2005
Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activityRegina Ortmann, Jochen Wiesner, Armin Reichenberg, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Business Economics|September 25, 2023
Distortional effects of separate accounting and formula apportionment on factor allocationRegina Ortmann, Erich Pummerer
Finance Research Letters|August 25, 2020
COVID-19 and investor behaviorRegina Ortmann, Matthias Pelster, Sascha Tobias Wengerek
Angewandte Chemie (International Ed. in English)|November 13, 2003
New antimalarial drugsJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
Archiv Der Pharmazie|November 13, 2007
Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activityJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
International Journal of Medical Microbiology : IJMM|August 18, 2012
The antimalarial pipeline--an updateFlorian C Schrader, Marlene Barho, Iljana Steiner, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katja Kettler, Jacek Sakowski, et al.
Archiv Der Pharmazie|September 7, 2007
Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residuesRegina Ortmann, Jochen Wiesner, Katrin Silber, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katharina Fucik, Katja Kettler, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activityRegina Ortmann, Jochen Wiesner, Armin Reichenberg, et al.
Archiv Der Pharmazie|July 5, 2005
Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activityRegina Ortmann, Jochen Wiesner, Armin Reichenberg, et al.
Pageof 2